Technology has come up with various treatment methods for improving health care outcomes. Wearable devices (WD) are starting to increasingly be used for interventions to promote well-being by reducing anxiety disorders (AD). Wearable brain stimulation technologies are easily available in the market. The newer technologies allow patients to treat their anxiety and other conditions at home for less money than traditional therapies with similar or even better results.
CES, rTMS, tDCS are the various alternative home treatment options for anxiety.
The best neuromodulation treatment option to choose between the above options for any patient will depend on the patient’s symptoms and goals.
Lets look at some wearable brain stimulation devices for anxiety which can be used as anxiety home treatment devices effectively.
Cranial Electrotherapy Stimulation (CES) for the treatment of Anxiety
Cranial electrotherapy stimulation is a prescriptive medical device that delivers a mild form of electrical stimulation to the brain for the treatment of anxiety, depression, and insomnia.
Cranial electrotherapy stimulation (CES) is a noninvasive therapeutic device that applies pulsed, alternating microcurrent (<1000 μA) transcutaneously to the head via electrodes placed on the earlobes, mastoid processes, zygomatic arches, or the maxillo-occipital junction. The U.S. Food and Drug Administration (FDA) granted approval in 1979 for CES for the treatment of insomnia, depression, and anxiety, and it is commercially available for personal use. It is supported by more than 40 years of research demonstrating its effectiveness in several mechanistic studies and greater than 100 clinical studies. Adverse effects are rare (<1%), mild, and self-limiting, consisting mainly of skin irritation under the electrodes and headaches.
Studies supporting Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia conclude that it can be often used as a stand-alone therapy, because results are usually seen from the first treatment, cranial electrotherapy stimulation may also be used as an adjunctive therapy.
Cervella is an FDA-Cleared CES device – Cervella Cranial Electrotherapy Stimulator is FDA-Cleared medical device for the treatment of anxiety, insomnia and depression. Cervella offers an alternative for patients who either respond poorly to anti-depressant drus or experience significant side-effects.
This device can be use used in conjunction with drug or any other therapy. This device is controlled through an app installed on patients smart device. Most patients notice improvements within couple of weeks of daily treatment. You need a prescription from a licensed healthcare practitioner (e.g. your doctor, nurse practitioner, psychologist, or therapist) to purchase Cervella. Contact Cervella suppliers if you need a referral to a local healthcare provider who is familiar with their device.
Repetitive Transcranial Magnetic Stimulation (rTMS) for anxiety Treatment
Repetitive transcranial magnetic stimulation (rTMS) neuromodulation for anxiety treatment has merits because it is non-invasive, well tolerated and safe. During the rTMS treatment, the rTMS coil is placed on the scalp, and at the meantime the coil is electrified so that a magnetic field is produced which could penetrate the skull to induce effects. The modulation effect of rTMS depends on the frequency, either decreasing or increasing cortical excitability. The prevailing hypothesis is that the after effects of high-frequency (usually 5 Hz or greater) stimulation are excitatory while those of stimulation with low frequency (1 Hz or less) are inhibitory. The US Food and Drug Administration has approved the high-frequency rTMS stimulation over the left dorsolateral prefrontal cortex (DLPFC) in treating resistant major depressive disorder (MDD). The anxiety symptoms have also been improved in patients with MDD following the rTMS, suggesting that rTMS may be a potential treatment for anxiety disorder. –
Efficacy and safety of repetitive transcranial magnetic stimulation for generalised anxiety disorder: A meta-analysis shows that the use of rTMS combined with medication treatment may have a significant positive anti-anxiety effect on patients with GAD.
Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Social Anxiety Disorder: Case Reports and a Review of the Literature show that application of low-rTMS over the right medial PFC combined with high-rTMS over the left mPFC, for at least 4 weeks on consecutive weekdays, may induce a balance in brain activity, opening an attractive therapeutic option for the treatment of anxiety.
Transcranial direct current stimulation (tDCS) for anxiety treatment
Transcranial direct current stimulation (tDCS) is a promising alternative treatment option and has been proven to be safe and well tolerated for the treatment of many diseases, including chronic pain, depression, and anxiety.
tDCS is a simple and cheap technique using two electrodes applied to the scalp. The anode (positive) depolarizes the neuronal membrane threshold, while the cathode (negative) hyperpolarizes it. This technique has been used in clinical settings using a range of stimulations from 1 to 2 mA of current, with the electrodes applied over specific areas of the brain, according to the required outcome.
tDCS is a well-tolerated method of neuromodulation that holds promise for the treatment of many diseases, and has been employed with therapeutic efficacy in patients with major depression (MD), chronic pain disorders, anxiety, and other conditions. Thus, non-invasive central neuromodulatory techniques can be considered as tools to treat or alleviate various anxiety symptoms. The use of off-label therapies, such as tDCS, tends to occur in the setting of diseases that are notoriously resistant to other treatment modalities.
Transcranial Direct Current Stimulation in Patients with Anxiety: Current Perspectives Studies evidence shows that tDCS may be more effective when used in combination with drugs and cognitive behavioral therapies.